Linkingmed is focused on establishing oncology data platform and medical data analysis.
LinkingMed Inc. focuses on building oncology data platform and medical data analysis. It offers AI and cloud based organ contouring, target delineation, automatic planning, radiotherapy quality assurance tools and services to radiotherapy department, third party medical imaging and radiotherapy centers. And it offers professional remote planning and radiotherapy network operation services to oncologists and medical physicists. LinkingMed Inc. keeps long-term and strategic collaboration with both international and domestic research and clinical institutes. It has applied more than ten national scientific funds and collaborated with NIH, Harvard Medical School, UT Southwestern Medical Center.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 3, 2019 | Series A | ¥40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Binhai Capital | — | Series A |